Prentiss Smith & CO Inc Abb Vie Inc. Transaction History
Prentiss Smith & CO Inc
- $142 Million
- Q1 2025
A detailed history of Prentiss Smith & CO Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Prentiss Smith & CO Inc holds 4,265 shares of ABBV stock, worth $725,732. This represents 0.63% of its overall portfolio holdings.
Number of Shares
4,265
Previous 4,500
5.22%
Holding current value
$725,732
Previous $799,000
11.76%
% of portfolio
0.63%
Previous 0.56%
Shares
15 transactions
Others Institutions Holding ABBV
# of Institutions
4,146Shares Held
1.29BCall Options Held
17MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$29.4 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$23.2 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$13.5 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$8.81 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$6.75 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $301B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...